BRITANNIA LIFE SCIENCES Market Cap ($5.69 Million)
Market Cap & Net Worth: BRITANNIA LIFE SCIENCES (L020)
BRITANNIA LIFE SCIENCES market cap. BRITANNIA LIFE SCIENCES (F:L020) has a market capitalization of $5.69 Million (€4.87 Million) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #28262 globally and #2429 in its home market, demonstrating a 15.38% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BRITANNIA LIFE SCIENCES's stock price €0.03 by its total outstanding shares 162254339 (162.25 Million). Also see L020 operating cash flow for how efficiently the company converts equity into cash flow.
BRITANNIA LIFE SCIENCES Market Cap History (2022–2026)
BRITANNIA LIFE SCIENCES market cap history from 2022 to 2026. Data shows change from $5.71 Million to $5.69 Million (-27.64% CAGR). Check L020 stock price and chart for real-time trading data and today's change.
BRITANNIA LIFE SCIENCES Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BRITANNIA LIFE SCIENCES's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of BRITANNIA LIFE SCIENCES to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
21.06x
BRITANNIA LIFE SCIENCES's market cap is 21.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.05x
BRITANNIA LIFE SCIENCES's market cap is 1.05 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $5.71 Million | $7.30 Million | -$15.46 Million | 0.78x | N/A |
| 2023 | $6.26 Million | $6.40 Million | $5.08 Million | 0.98x | 1.23x |
| 2024 | $7.30 Million | $516.83K | -$4.77 Million | 14.13x | N/A |
| 2025 | $7.78 Million | $369.28K | $7.39 Million | 21.06x | 1.05x |
Competitor Companies of L020 by Market Capitalization
Companies near BRITANNIA LIFE SCIENCES in the global market cap rankings as of November 3, 2026. Also see how large is BRITANNIA LIFE SCIENCES's balance sheet for a full breakdown of the balance sheet.
Key companies related to BRITANNIA LIFE SCIENCES by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of BRITANNIA LIFE SCIENCES (2022–2026)
Market capitalization of BRITANNIA LIFE SCIENCES from 2022 to today. Between 2022 and today, BRITANNIA LIFE SCIENCES's market cap moved from $5.71 Million to $ 5.69 Million, with a yearly change of -27.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €5.69 Million | -26.83% |
| 2025 | €7.78 Million | +6.49% |
| 2024 | €7.30 Million | +16.67% |
| 2023 | €6.26 Million | +9.63% |
| 2022 | €5.71 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 2nd, 2026 the market cap of BRITANNIA LIFE SCIENCES was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.69 Million USD |
| MoneyControl | $5.69 Million USD |
| MarketWatch | $5.69 Million USD |
| marketcap.company | $5.69 Million USD |
| Reuters | $5.69 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BRITANNIA LIFE SCIENCES
Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. It serves cosmetics, consumer packaged and household goods, and nutraceutical industries. The company is headquartered in Toronto, Canada.